Our results were in accordance with the positive correlation observed between α6-integrin expression and its target genes ZEB1, YAP1, FGFR1, and FOXM1 in GBM from two different databases, including respectively 539 and 184 patients. The gene discussed is FGFR1; the disease is glioblastoma.